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SUPPLEMENTARY NOTES
ABSTRACT
This hypothesis development project tested the feasibility of identification, laser capture microdissection, and expression analysis of prostate-stroma specific cells in normal and cancerous prostates, and aims to develop preliminary data sufficient to identify potential differences in stromal RNA expression in normal and cancerous prostate tissue. Our studies found that it is difficult but not impossible to histologically identify prostate zones with an acceptable degree of confidence in frozen tissues, eliminating the need to attempt expression studies in fixed tissues with their attendant biases. LCM of stromal tissue was completed for 6 normal prostates from men across the age range and of the two racial groups studied, and from prostates from men of similar ages with adenocarcinoma identified distant from the area of dissection. High Quality RNA was isolated, and duplicate Affymetrix Plus 2.0 chip analysis performed. We observe potentially significant expression differences in both normal epithelial and stromal cells from fully normal prostates as compared to prostates containing adenocarcinoma which are now subject to formal hypothesis testing. 
SUBJECT TERMS
Body
Please note that because this is a Hypothesis Development Award project, no statement of work was required or provided as part of the original funded proposal. Nonetheless, the primary goal and steps required to complete the project were clearly identified in the original application.
As in any well-managed research project, we have kept our eyes on the goal, while changing tactics and methods to adjust to our own and outside research progress as the study progressed.
The following is a list of the main steps taken toward reaching the goal of this study:
1. Histologic analysis of available normal prostate sections from frozen and fixed (alcohol or formalin) tissue to identify tissue blocks which we can reliably be identified as containing prostate anatomic subzones (Central Zone, Peripheral Zone, Transition Zone, as illustrated in Figure 1 ). This was covered in our interim study reports. This was far more time-consuming than expected, but was completed successfully together with our prostate histology expert Dr. De Marzo.
2. Decision to use only frozen tissues for RNA expression analysis for this pilot study based on discussion and careful review of current literature on using fixed tissues for RNA analysis. While many have reported the use of fixed tissues for RNA analysis, this method has limitations which should be avoided if sufficient frozen tissues are available. Analysis of the number and type of available tissues showed that we likely have sufficient frozen normal prostate for hypothesis development. If successful, this eliminates one layer of potential data confounding. Central Zone Transition Zone Peripheral Zone 3. Continued work on improving function of our integrated database application to manage data emanating from the project. Our main focus has been on integrating RNA expression results with Tissue Microarray staining results. Because most current studies linking phenotype (cancer/normal for example) with molecular data (expression of specific gene products for example) do not have database control of all of their data, most expression studies to date report large amounts of data but do not stand up to recurrent hypothesis testing. With every new study performed in our laboratory, we attempt to improve these linkages to allow our science to continue to improve. This was covered in our previous progress report.
4. Decision to complete the study in collaboration with the Laboratory of Cancer Genetics, National Cancer Institute, headed by Dr. Michael Emmert-Buck. Our laboratories have a long history of collaboration, and our research interests are complementary. Together, we decided to widen the scope of the study to compare both epithelial and stromal RNA expression.
Six of the normal cases identified above and six cases containing tumor foci elsewhere in the gland (from the Emmert-Buck laboratory) were laser-capture microdissected for normal-appearing epithelium, and normal appearing stroma. RNA was then extracted using the PicoPure RNA Extraction Kit (Molecular Devices) and subjected to a quality and quantity control assessment. Quality of RNA was evaluated using an Agilent 2100 Bioanalyzer for RIN and 28S/28S ratios. Quantity was measured using a NanoDrop Spectrophotometer. Two rounds of linear oligo-dT amplification using the MessageAmp II Kit (Ambion) to amplify messenger RNA for GeneChip analysis. After a second Bioanalyzer step to confirm amplification, mRNA were fragmented and hybridized to oligo-nucleotide arrays (Affymetrix U133 Plus 2.0 GeneChips). The GeneChips contain over 54,000 probe sets and were run in technical replicates for quality assurance.
Laser-capture microdissection went smoothly, with an average of 4,180 shots being taken for epithelial samples and 20,359 shots taken for stromal samples. A five-fold increase in shot number was necessary for stromal areas to increase RNA yield because it is a relatively cellularpoor region. Extracted RNA from each region averaged 13.49 ng/ul for the epithelium, and 8.33 ng/ul for the stromal samples. Quality assessment revealed 28S/18S ratios of 1.48 and 1.10 for the epithelium and stroma, respectively, and RINs (RNA Integrity Numbers) of 7.90 and 7.18, respectively as well, indicating high quality RNA suitable for expression array analysis. All of the gene chip hybridizations were completed as of Friday, January 19, 2007.
5. Analysis of Affymetrix expression data. The NCI mAdb array data analysis package was used to compare expression levels between groups. The most significant observations to emerge from these comparisons are summarized in the four tables below. Table 3 : BioCarta and KEGG molecular pathway-based differences detected between normal epithelium from older subjects with prostate cancer and normal epithelium from prostates from younger subjects without cancer (red: upgregulated, green:downregulated) Table 4 : KEGG molecular pathway-based differences detected between normal stroma from older subjects with prostate cancer and normal stroma from prostates from younger subjects without cancer (red: upgregulated, green:downregulated). Results in Tables 1-4 raise several tantalizing general and specific hypotheses regarding agingassociated changes potentially relevant to prostate carcinogenesis. Specifically interesting are the marked increases in focal adhesion and other adhesion pathway members, MAPK pathway members and extracellular matrix receptor interaction pathway members in older epithelium vs younger epithelium. These observations are in some ways opposite of what might be expected and are therefore very interesting. Perhaps these changes are part of an evolved mechanism to suppress cancer globally in prostate as aging occurs, a general phenomenon that to our knowledge has not previously been considered.
# of Features BioCarta Pathway
We were not expecting to find such high level differences in expression between younger and older normal prostate epithelium and stroma. Because these findings have high potential importance if true, prior to attempting validation of specific pathway members through real time PCR and related studies, we have elected to expand the number of dissections and Affymetrix hybridizations, and add additional controls to the study to rule out tissue collection method artifact as the source of the above differences. Tissue samples studied in each group reported above are similar in that they are from well preserved frozen material, but they differ in that the normal prostates derive from transplant donors and were removed just after organs were removed for transplantation, and the noncancerous normal prostate tissue from older men with localized prostate cancer derived from surgery. To rule out the possibility of collection method artifact, and to better understand the role of the presence of cancer in the older normal prostates studied, we are now expanding the number of normal prostates from transplant donors in the study, to allow statistically significant age (and race) related comparisons to be performed from samples derived from transplant donors alone. Additional samples of "normal" prostate adjacent to localized prostate cancer will also be dissected and added to the study. These studies will be completed in the coming year using funds outside of this Hypothesis Development award. As the expanded study is completed and submitted for publication, affymetrix data will be submitted to the GEO database. None so far. If initial data holds true with broadening and deepening of study as described, the findings could be very helpful in advancing understanding of aging related physiology which likely to be important in increasing prostate cancer risk with aging.
Conclusions:
Feasibility and value of studying well-curated, high quality normal prostate tissue from individual of varying age and race is confirmed. Specific conclusions suggested by initial analysis above to be firmed up with extension of study as described.
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